Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe site revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved a general site-wide notice about government funding and operating status; this change does not affect the study details, eligibility criteria, or trial data.SummaryDifference0.4%

- Check40 days agoChange DetectedThe two screenshots show the same Study Details page (NCT03430791) with identical sections such as Brief Summary, Eligibility, Interventions, and Study Dates; no additions or deletions detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor addition: a prominent operating-status notice for users and a v3.2.0 release tag replaces the prior v3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page updated to revision v3.0.2 (from v3.0.1), and the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.